Latest news for Acrux (OTC:ARUXF) Stock

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

Acrux Ltd

Acrux Limited (AU:ACR) has released an update. Acrux Limited has successfully launched Dapsone Gel, 5% for acne treatment in the US market and secu...

Acrux Limited Expands Product Line and Secures R&D Funding

Acrux Limited (AU:ACR) has released an update. Acrux Limited has announced FDA approval for its generic Dapsone Gel, 7.5%, marking the company's fi...

Acrux Limited Clinches FDA Nod for Acne Treatment

Acrux Limited (AU:ACR) has released an update. Acrux Limited, an Australia-based specialty pharma company, has released its Appendix 4G and Corpora...

Acrux Limited Publishes Annual Governance Reports

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialty pharma company known for developing and marketing topical pharmaceuticals...

Acrux Limited Faces Revenue Decline and Losses

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialty pharma company known for developing topically applied pharmaceutical prod...

Acrux Limited Announces FY24 Results Webinar

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialist in developing and commercializing topically applied prescription pharmac...

Acrux Limited Cautions on Future Projections

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialty pharma company, announced its participation in the ASX Small and Mid Cap ...

Acrux Limited Spotlights at ASX Conference

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialty pharmaceutical company, has announced its Annual General Meeting (AGM) fo...

Acrux Limited Announces 2024 AGM for Shareholders

Acrux Limited (AU:ACR) has released an update. Acrux Limited is set to boost its revenue stream with the approval and upcoming launch of Dapsone 7....

Acrux Limited Eyes Revenue Growth with New Product Launches

Acrux Limited (AU:ACR) has released an update. Acrux Limited, a specialty pharmaceutical company known for its expertise in developing topical prod...

Comments

Acrux

News

Latest news for Acrux (OTC:ARUXF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga